![]() |
市場調查報告書
商品編碼
1951200
牙科生醫材料市場-全球產業規模、佔有率、趨勢、機會及預測(按類型、應用、最終用戶、地區和競爭格局分類,2021-2031年)Dental Biomaterials Market- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Type, By Application, By End User, By Region & Competition, 2021-2031F |
||||||
全球牙科生物材料市場預計將從 2025 年的 85.3 億美元成長到 2031 年的 121.9 億美元,複合年成長率為 6.13%。
這些生物材料由多種生物相容性合成和天然物質組成,旨在修復受損結構、取代缺牙和再生口腔組織。此市場成長的主要驅動力是全球人口老化導致修復治療需求增加以及牙周疾病盛行率上升。此外,消費者對美容牙科和美容手術的強勁需求也為行業的持續成長奠定了堅實的基礎;這些基本成長要素使該市場區別於曇花一現的技術潮流。
| 市場概覽 | |
|---|---|
| 預測期 | 2027-2031 |
| 市場規模:2025年 | 85.3億美元 |
| 市場規模:2031年 | 121.9億美元 |
| 複合年成長率:2026-2031年 | 6.13% |
| 成長最快的細分市場 | 陶瓷生物材料 |
| 最大的市場 | 北美洲 |
然而,新興經濟體中先進牙科治療的高成本以及保險覆蓋範圍的不足,對市場滲透構成了重大挑戰。這些經濟限制導致大量患者無法獲得治療。儘管面臨這些經濟壓力,牙科產業仍保持強勁勢頭。根據美國牙醫協會(ADA)統計,截至2025年8月,美國消費者牙科支出較年初成長4%,顯示市場對耗材密集牙科服務的需求持續強勁。
人工植牙和修復方案日益普及是推動該產業發展的關鍵因素,並顯著增加了骨移植材料、屏障膜和骨整合材料的消耗量。隨著患者越來越傾向於選擇固定修復體而非活動義齒,對具有長期穩定性的先進生物相容性材料的需求也隨之飆升。這一趨勢在主要行業參與者的業務量中得到了清晰的體現,接受修復治療的患者數量不斷增加。例如,士卓曼集團在2024年年度報告(2025年2月發布)中指出,預計2024年將完成670萬例治療,比上年度增加110萬例。患者數量的成長直接推動了用於牙槽骨增量和牙槽窩保存手術的合成材料和異種移植材料需求的成長。
同時,齲齒和牙周疾病發生率的上升確保了治療量的穩定,從而維持了對修復用複合樹脂、黏固劑和再生劑的需求。治療頻率的增加,加上醫療基礎設施的改善和病患就醫管道的擴大,正推動材料使用量的顯著成長。根據英國國家醫療服務體系(NHS)商業服務機構2025年8月發布的報告《NHS牙科統計-英格蘭2024-25》,2024-25會計年度將進行3,500萬次治療,較上一季成長4%。這種經濟活動的復甦提振了材料製造商的財務業績,他們正充分利用對修復治療的持續需求,例如,Envista Holdings Corporation在2025年第三季的核心銷售額達到6.7億美元,年增9.4%。
與先進牙科治療相關的成本不斷上漲,嚴重阻礙了優質牙科生物材料的廣泛應用。合成骨移植材料、薄膜和修復複合材料的採購價格上漲,使得牙醫診所的營運成本成長幅度遠超其成長比例。當保險公司和公共衛生系統的報銷率未能相應調整以反映這些不斷上漲的投入成本時,牙科專業人士便失去了使用優質生物材料的經濟獎勵。這種價格敏感性迫使診所要麼自行承擔虧損,要麼選擇更便宜、品質更低的替代品,從而限制了尖端材料的銷量,並限制了其在富裕患者群體中的市場滲透。
供應鏈的通膨壓力進一步加劇了這項財務負擔,直接侵蝕了維持材料密集產業所需的利潤率。隨著採購成本的上升,醫療服務成本與可用資金之間的差距不斷擴大,導致存貨周轉停滯不前。根據美國牙醫協會 (ADA) 2025 年的一項調查,大多數受訪牙科診所表示,自年初以來,設備和耗材的價格上漲了 5% 以上。材料成本的大幅上漲,而報銷額卻沒有相應增加,這正在降低主要終端用戶的購買力,並直接抑制全球牙科生物材料市場的成長。
不斷擴展的數位和3D列印材料產品組合正在從根本上改變臨床工作流程,使高精度複雜器材的直接製造成為可能。這一趨勢的特點是,越來越多的專用生物相容性樹脂和熱塑性材料被採用,它們能夠與CAD/CAM生態系統無縫協作,有效取代傳統的模擬印模材料。隨著牙科專業人士將效率放在首位,用於隱形矯正器和3D列印義齒的數位化最佳化材料的使用量正在加速成長,促使製造商不斷豐富其配方。根據Align Technology於2025年10月發布的2025年第三季財務報告,隱形矯正器的交易量達到647,800套,較去年同期成長4.9%,這顯示數位化材料產業在矯正治療領域持續擴張。
同時,受患者對卓越美觀性和無金屬修復體的需求推動,市場對高滲透性鋯和全瓷修復體的需求正在飆升。這種市場轉變加速了瓷製熔附金屬(PFM)支架的衰落,取而代之的是兼具高斷裂韌性和天然光學特性的整體式材料。口內掃描器的整合進一步促進了這一轉變,使數位化印模能夠與加工削磨機無縫對接,從而快速生產這些陶瓷修復體。根據Modern Dental Group發布的《2025年中期報告》(2025年8月),該公司主要工廠的數位化修復體產量將達到約457,653件,同比成長24.4%,這反映了市場對銑床陶瓷系統的壓倒性偏好。
The Global Dental Biomaterials Market is projected to expand from USD 8.53 Billion in 2025 to USD 12.19 Billion by 2031, reflecting a Compound Annual Growth Rate (CAGR) of 6.13%. These biomaterials consist of a variety of biocompatible synthetic and natural substances designed to repair damaged structures, replace missing teeth, or regenerate oral tissues. The market is primarily propelled by an aging global population requiring restorative care and an increasing prevalence of periodontal disorders. Furthermore, strong consumer preference for aesthetic dental improvements and cosmetic procedures establishes a solid foundation for continued industry growth, distinguishing these fundamental drivers from temporary technological trends.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 8.53 Billion |
| Market Size 2031 | USD 12.19 Billion |
| CAGR 2026-2031 | 6.13% |
| Fastest Growing Segment | Ceramic Biomaterials |
| Largest Market | North America |
However, the high cost of advanced dental treatments and insufficient reimbursement coverage in emerging economies pose significant challenges that could hinder broader market adoption. These financial constraints limit accessibility for a large segment of the patient population. Despite these economic pressures, the sector remains resilient; according to the American Dental Association, consumer dental spending in the United States rose by 4% as of August 2025 compared to the beginning of the year, underscoring the sustained demand for material-intensive dental services.
Market Driver
The increasing penetration of dental implants and restorative solutions acts as a vital catalyst for the sector, substantially boosting the consumption of bone grafts, barrier membranes, and osseointegrative substances. As patients increasingly favor fixed prosthetic options over removable dentures, the need for advanced biocompatible materials that offer long-term stability has surged. This trend is evident in the operational scale of key industry players seeing higher patient numbers for replacement therapies. For instance, the Straumann Group reported in its 'Annual Report 2024' (February 2025) that the organization supported 6.7 million smiles in 2024, an increase of 1.1 million patients from the prior year. This rise in patient volume directly drives intensified demand for synthetic and xenogeneic substitutes used in ridge augmentation and socket preservation.
Concurrently, the rising incidence of dental caries and periodontal diseases ensures a steady volume of interventions, maintaining demand for restorative composites, cements, and regeneration agents. As healthcare infrastructure improves and patient access widens, the frequency of treatments fuels substantial material utilization. According to the NHS Business Services Authority's August 2025 report, 'NHS Dental Statistics - England 2024-25', 35 million courses of treatment were delivered during the 2024-25 financial year, a 4% increase from the previous period. This rebound in activity supports the financial performance of material manufacturers, as shown by Envista Holdings Corporation, which achieved third-quarter sales of $670 million in 2025 with 9.4% year-over-year core sales growth, illustrating strong capitalization on these persistent restorative care demands.
Market Challenge
The elevated cost associated with advanced dental treatments creates a severe economic barrier that limits the widespread adoption of premium dental biomaterials. When the acquisition price of synthetic bone grafts, membranes, and restorative composites rises, the operational overhead for dental practices increases disproportionately. If reimbursement rates from insurance providers or state healthcare systems do not adjust to match these rising input costs, dental professionals face financial disincentives to use top-tier biomaterials. This price sensitivity often forces practitioners to absorb the deficit or choose less expensive, lower-quality alternatives, effectively capping the sales volume of advanced materials and restricting market penetration to affluent patient demographics.
This financial strain is further exacerbated by inflationary pressures on the supply chain, which directly erode the profit margins necessary to sustain a material-intensive industry. As procurement costs climb, the gap between the expense of delivering care and available funding widens, leading to stagnated inventory turnover. According to the American Dental Association in 2025, the majority of surveyed dental practices reported that prices for equipment and supplies had increased by more than 5% since the start of the year. This measurable rise in material costs, without a commensurate increase in reimbursement, directly hampers the growth of the Global Dental Biomaterials Market by reducing the purchasing power of primary end-users.
Market Trends
The expansion of digital and 3D-printable material portfolios is fundamentally transforming clinical workflows by enabling the direct fabrication of complex appliances with high precision. This trend is defined by the increasing adoption of specialized biocompatible resins and thermoplastics that operate seamlessly within CAD/CAM ecosystems, effectively replacing traditional analog impression materials. As dental professionals prioritize efficiency, the consumption of these digitally optimized materials for clear aligners and printed prosthetics has accelerated, driving manufacturers to broaden their formulations. According to Align Technology's 'Q3 2025 Financial Results' from October 2025, clear aligner volume increased by 4.9% year-over-year to 647.8 thousand cases, demonstrating the sustained industrial scale of digital material utilization in orthodontic treatments.
Simultaneously, there is a surge in demand for high-translucency zirconia and all-ceramic solutions, driven by patient requirements for superior aesthetics and metal-free restorations. This market shift is accelerating the decline of porcelain-fused-to-metal frameworks in favor of monolithic materials that combine high fracture toughness with natural optical properties. The integration of intraoral scanners further catalyzes this transition, as digital impressions seamlessly interface with milling units to produce these ceramic restorations rapidly. According to the Modern Dental Group's 'Interim Report 2025' (August 2025), the volume of digital solution cases produced at its major facilities increased by 24.4% year-over-year to approximately 457,653 units, reflecting the dominant market preference for millable ceramic systems.
Report Scope
In this report, the Global Dental Biomaterials Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Dental Biomaterials Market.
Global Dental Biomaterials Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: